Intervention Review

Aminoadamantanes for chronic hepatitis C

  1. Mieke H Lamers1,2,*,
  2. Mark Broekman1,
  3. Joost PH Drenth1,
  4. Christian Gluud2

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 3 MAY 2014

Assessed as up-to-date: 30 MAR 2014

DOI: 10.1002/14651858.CD010125.pub2


How to Cite

Lamers MH, Broekman M, Drenth JPH, Gluud C. Aminoadamantanes for chronic hepatitis C. Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD010125. DOI: 10.1002/14651858.CD010125.pub2.

Author Information

  1. 1

    Radboud University Medical Center Nijmegen, Department of Gastroenterology and Hepatology, Nijmegen, Netherlands

  2. 2

    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, The Cochrane Hepato-Biliary Group, Copenhagen, Denmark

*Mieke H Lamers, m.lamers@mdl.umcn.nl.

Publication History

  1. Publication Status: New
  2. Published Online: 3 MAY 2014

SEARCH

  1. Current Version

    Aminoadamantanes for chronic hepatitis C

    Mieke H Lamers, Mark Broekman, Joost PH Drenth and Christian Gluud

    Article first published online: 3 MAY 2014 | DOI: 10.1002/14651858.CD010125.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Aminoadamantanes for chronic hepatitis C

    Mieke H Lamers, Mark Broekman, Joost Drenth and Christian Gluud

    Article first published online: 12 SEP 2012 | DOI: 10.1002/14651858.CD010125